Compare SRCE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRCE | ATRC |
|---|---|---|
| Founded | 1863 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | 2005 |
| Metric | SRCE | ATRC |
|---|---|---|
| Price | $68.89 | $32.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $73.25 | $52.22 |
| AVG Volume (30 Days) | 114.4K | ★ 519.4K |
| Earning Date | 01-23-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 19.59 | N/A |
| EPS | ★ 6.41 | N/A |
| Revenue | $421,216,000.00 | ★ $518,304,999.00 |
| Revenue This Year | $9.25 | $16.94 |
| Revenue Next Year | $3.29 | $12.54 |
| P/E Ratio | $10.85 | ★ N/A |
| Revenue Growth | 12.43 | ★ 15.80 |
| 52 Week Low | $52.14 | $28.29 |
| 52 Week High | $71.00 | $43.18 |
| Indicator | SRCE | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 59.95 | 33.47 |
| Support Level | $67.40 | $36.11 |
| Resistance Level | $71.00 | $38.07 |
| Average True Range (ATR) | 1.80 | 1.64 |
| MACD | 0.17 | -0.31 |
| Stochastic Oscillator | 65.28 | 25.24 |
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.